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Abstract

The rate-limiting step in the steroid synthesis pathway is catalyzed by CYP11A1 through three
sequential reactions. The first two steps involve hydroxylations at positions 22 and 20,
generating 20(R),22(R)-dihydroxycholesterol (20R,22R-DiOHCH), with the third stage leading to a
C20–C22 bond cleavage, forming pregnenolone. This work provides detailed information about
the active site structure of CYP11A1 in the resting state and substrate-bound ferric forms as well
as the CO-ligated adducts. In addition, high-quality resonance Raman spectra are reported for
the dioxygen complexes, providing new insight into the status of Fe–O–O fragments
encountered during the enzymatic cycle. Results show that the three natural substrates of
CYP11A1 have quite different effects on the active site structure, including variations of spin
state populations, reorientations of heme peripheral groups, and, most importantly, substratemediated distortions of Fe–CO and Fe–O2 fragments, as revealed by telltale shifts of the
observed vibrational modes. Specifically, the vibrational mode patterns observed for the Fe–O–
O fragments with the first and third substrates are consistent with H-bonding interactions with
the terminal oxygen, a structural feature that tends to promote O–O bond cleavage to form the
Compound I intermediate. Furthermore, such spectral data are acquired for complexes with the
natural redox partner, adrenodoxin (Adx), revealing protein–protein-induced active site
structural perturbations. While this work shows that Adx has an only weak effect on ferric and
ferrous CO states, it has a relatively stronger impact on the Fe–O–O fragments of the
functionally relevant oxy complexes.
Steroidogenic cytochromes P450 participate in the synthesis of steroid hormones that are
essential for the maintenance of mammalian life.(1-3)Ultimately, all of these crucial hormones
are generated from a common parent hormone, pregnenolone, which is derived from
cholesterol in a complex process mediated by the multifunctional steroidogenic P450, CYP11A1.
This inner mitochondrial membrane protein of the adrenal cortex is also known as cytochrome
P450scc, a designation that refers to the catalyzed side cleavage reaction occurring between
C20 and C22 (Figure 1). This rate-limiting step in the steroid synthesis pathway is catalyzed by
CYP11A1 through three sequential steps illustrated in Figure 1, where the first two steps convert
cholesterol (CH) to 22(R)-hydrocholesterol (22R-OHCH) and then to 20(R),22(R)dihydroxycholesterol (20R,22R-DiOHCH), with the third stage leading to C20–C22 bond cleavage,
thereby forming the key product, pregnenolone, and another small molecule, 4-methylpentanal
(also called isocaproaldehyde).(4-7)

Figure 1. Structures of intermediate products encountered during the conversion of cholesterol
to pregnenolone.
The well-established enzymatic cycle of cytochromes P450 is initiated by the substrate binding
to a low-spin ferric “resting state”, which disrupts a water cluster, displacing a bound axial water
ligand, generating a high-spin ferric heme, with an elevated reduction potential that triggers
acceptance of an electron.(1, 2) In the case of CYP11A1, the electron is provided by NADPHassociated adrenodoxin reductase (AdR) and delivered by an Fe–S cluster contained in
adrenodoxin (Adx).(8, 9) Binding of molecular oxygen forms a dioxygen adduct, which is most
properly formulated as a ferric superoxide species, Fe(III)–(O–O–).(10-13) Delivery of another
electron from Adx then produces a ferric peroxo intermediate, Fe(III)–(O–O2–). While special
situations in which this ferric peroxo species can react directly with electron-deficient fragments
of a given substrate do exist,(14, 15) generally, rapid sequential delivery of two heme-pocket
protons first forms a transient hydroperoxo species that then undergoes efficient O–O bond
cleavage to generate an extremely potent oxidant, known as Compound I, which is most
accurately formulated as a ferryl heme π cation radical, i.e., [(porphyrin+•)Fe(IV)═O].(16-22)
Interaction with natural or alternative reductases can alter the function and possibly the active
site structure of the cytochrome P450.(1, 2, 14, 23-25)Adrenodoxin (Adx), which contains a [2Fe2S] cluster, is generally believed to serve as an electron shuttle between a NADPH-containing
enzyme, adrenodoxin reductase (AdR), and the active site of CYP11A1.(9, 23-25) It has been
reported that the inherent reduction potential of substrate-bound CYP11A1 is −284 mV and that
for Adx is −273 mV, with protein–protein complex formation causing the reduction potential of
Adx to undergo a small negative shift to −291 mV, while that of CYP11A1 shifts to −312 mV.(26,
27)The association of Adx and CYP11A1 is postulated to arise from electrostatic interactions of
charged surface residues of Adx and CYP11A1,(9) with the recently reported crystal structure of
the fusion protein between Adx and CYP11A1 revealing the presence of two salt bridges,
consistent with this suggestion: Lys339 (CYP11A1)–Asp72 (Adx) and Lys343 (CYP11A1)–Asp76
(Adx).(28)
Resonance Raman (rR) spectroscopy has been applied to study various heme proteins and
enzymes for decades,(29, 30) permitting determinations of spin population
change,(31) distortions of the heme as reflected in variations of the in-plane and out-of-plane
macrocycle modes,(29, 30, 32-37) and interactions of the vinyl and propionate groups on the
heme periphery, as reflected in the behavior of the propionate and vinyl bending modes
appearing in the low-frequency region and the vinyl group ν(C═C) stretching modes that are

observed near 1600–1640 cm–1, both of which are sensitive to out-of-plane displacements of
these groups with respect to the mean heme plane.(32, 38-41) Also, the technique is an
especially powerful probe of the disposition of various endogenous and exogenous heme axial
ligands. For example, the behavior of ν(Fe–C) and ν(C–O) for ferrous CO forms reveal detailed
information about the polarity of the distal pocket.(42) Of special importance for this work is the
fact that the ν(Fe–O) and ν(O–O) modes of the oxy form of cytochromes P450 are efficiently rRenhanced and provide telltale vibrational data that reflect subtle, but functionally important, Hbonding interactions with distal side molecular fragments, including those of bound
substrates.(42-44) Also important for the study presented here is the fact that rR is able to
probe the status of the key ν(Fe–S) mode.(32, 45-48) Moreover, rR measurements can monitor
the effects of redox partners on the heme active sites for all of the forms mentioned above.(4850)
Early rR studies of CYP11A1 were reported mainly by Tsubaki et al.,(50-52) for the ferric and
ferrous CO states, providing some valuable insight, but also leaving some unexplained issues of
interpretation, which are further addressed here (vide infra). Most importantly, in the work
presented here, we also expand the rR investigation of CYP11A1 to studies of the dioxygen
complexes, ordinarily fleeting intermediates that must be prepared and stabilized under lowtemperature conditions.(12, 43, 44) rR spectroscopy studies of such dioxy intermediates can
reveal even subtle active site structural changes that significantly impact the disposition of
crucial intermediates and influence alternative reaction pathways that may occur within these
enzymatic cycles.(43, 44, 53) For example, the rR technique can differentiate H-bonding to the
proximal oxygen (Fe–Op) in an Fe–Op–Ot fragment, leading to a lower ν(Fe–O)frequency, and Hbonding to the terminal oxygen (Ot), which yields a relatively higher ν(Fe–O) frequency.(42-44,
54) This is a quite important capability, because computational work on cytochromes P450 and
NOS,(55, 56) as well as experimental work on NOS and truncated hemoglobins,(57-59) has
indicated that hydrogen bonding to the proximal oxygen will stabilize the peroxo intermediate,
thereby hindering cleavage of the O–O bond, making it more likely that a (susceptible) substrate
will be processed through the peroxo intermediate.(53, 55-59) On the other hand, hydrogen
bonding to the terminal oxygen atom favors heterolytic cleavage of the O–O bond, with the
reaction inevitably proceeding though the Compound I intermediate.(16-22)
Our work provides detailed information about the active site structure of CYP11A1 in the resting
state and substrate-bound ferric forms, the CO-ligated adducts, and the dioxy intermediates
encountered in the enzymatic cycle. In addition, studies of the forms mentioned above in
complex with the natural redox partner, Adx, interrogating protein–protein-induced active site
structural perturbations are conducted. Specifically, the results show that the three natural
substrates of CYP11A1 have quite different effects on the active site structure, including
variations in spin state populations, reorientations of heme peripheral groups, and, most
importantly, substrate-mediated distortions of the Fe–XY fragments of bound exogenous
ligands, including CO and O2, as revealed by telltale shifts of the ν(X–Y), ν(Fe–X), and δ(Fe–X–Y)
vibrational modes. On the other hand, most significantly, our results reveal that the vibrational
mode patterns observed for the Fe–O–O fragments of the dioxygen adducts obtained with the
first and third substrates are almost identical, being consistent with H-bonding interactions to
the terminal oxygen, a structural feature that tends to promote O–O bond cleavage, leading to

reactions mediated by a Compound I species, consistent with the conclusions of recent
experimental work mentioned above.(60-62) Moreover, the effect of the binding of
adrenodoxin to all three forms of CYP11A1 (ferric, ferrous CO, and oxygenated) was studied and
shows that, although Adx has an only weak effect on ferric and ferrous CO states, it is seen for
the first time that it has a relatively stronger impact on the Fe–O–O fragments of the
functionally relevant oxy complexes.

Materials and Methods
Materials

The substrates, CH and 22R-OHCH, were purchased from Sigma-Aldrich (Milwaukee, WI), and
20R,22R-DiOHCH was purchased from Cayman Chemical (Ann Arbor, MI). 22R-OHCH and
20R,22R-DiOHCH were dissolved in an ethanol solution to make 25 mM stock solutions.

Protein Preparation

Adrenodoxin (Adx) and CYP11A1 were purified from adrenal glands purchased from a local
harvesting plant (Cargill, Milwaukee, WI). The purification processes were performed, as
described in the Supporting Information, according to published procedures.(23, 63, 64)

Sample Preparation for Resonance Raman

CYP11A1 purified from the adrenal cortex by the procedure described above is recovered in a
form that retains the natural substrate, cholesterol. The concentration of CYP11A1 for samples
of the ferric and ferrous CO forms was 100 μM in 100 mM phosphate buffer (pH 7.4) containing
0.1 mM dithiothreitol (DTT) and 0.1 mM ethylenediaminetetraacetic acid (EDTA). The
concentration of enzyme in the samples used for measurement of the ν(Fe–S) stretching
frequencies was 200 μM in 10 mM phosphate buffer (pH 7.4), 0.1 mM DTT, and 0.1 mM EDTA.
The Adx:CYP11A1 ratio was 1.2:1 for those samples containing Adx, noting that the samples
containing the redox partner were incubated overnight at 4 °C to ensure full binding of Adx. For
the generation of CYP11A1 samples bound with the other substrates, advantage was taken of
the fact that the binding affinity of the other two substrates, 22R-OHCH and 20R,22R-DiOHCH, is
much higher than that of cholesterol, enabling them to displace the cholesterol from the active
site. Thus, these substrate-bound samples were made by adding, from an ethanol stock solution,
a 3–5-fold molar excess of the hydroxycholesterol and incubating the samples overnight at 4 °C
to ensure full exchange.(12, 65)
With regard to the preparation of the various ligated forms, the ferrous CO adducts were made
by addition of an excess amount of reducing agent, sodium dithionite (Na2S2O4), from a stock
solution. A 100 μL aliquot of 100 μM CYP11A1 was placed in a nuclear magnetic resonance
(NMR) tube (WG-5 Economy, Wilmad) and sealed with a rubber septum (Sigma-Aldrich). The
tube was connected to a vacuum line with a needle connection. The sample was sparged three
times by exchange with Ar gas and then exchanged twice with CO gas to ensure the sample was
saturated with CO. A freshly prepared solution of sodium dithionite dissolved in an Ar-degassed
buffer was added to the solution of CYP11A1. The ferric sample was reduced by addition of ∼2
molar equivalents of a sodium dithionite solution (8 μL). The ultraviolet spectrum was
monitored over the next few minutes, showing a sharp band rising at ∼550 nm and a band

disappearing at ∼645 nm, which can be attributed to the HS ferric form; the solution was
allowed to incubate for 15 min to ensure full conversion.

The oxygenated samples of CYP11A1 were prepared from the ferric samples in the following
manner. A 100 μL aliquot of a 200 μM ferric sample was placed in a NMR tube and connected to
a vacuum line tube adapter. On the vacuum line, the sample was alternately degassed and filled
with Ar for three cycles. Addition of a freshly degassed sodium dithionite solution was made by
using a gastight syringe through a rubber septum on the vacuum line system into the ferric
sample. The NMR tube was gently tapped to allow the sample to mix well. In practice, the
sample was titrated with the a sodium dithionite solution until the sharp band at ∼550 nm
reached a maximum and the band at ∼645 nm had disappeared, as monitored by a special
device (model CHEM2000-VIS, Ocean Optics Inc., Dunedin, FL) that is capable of recording
absorption spectra from samples contained in NMR tubes (WG-5 Economy, Wilmad). Then
oxygen was added to this ferrous sample by bubbling 16O or 18O gas, using a vortex mixer to
gently agitate the sample. During the reduction and oxygenation steps, the sample tube was
placed in an ice-cold bath at 0 °C. The mixing time for oxygenation was different, depending on
the substrate being studied; the samples containing the first two substrates, CH without Adx and
22R-OHCH without Adx, were mixed for 30 s, but the sample containing 20R,22R-DiOHCH
without Adx required mixing for 90 s to complete formation of the oxy form.(13) These relatively
short mixing times were used, because under these conditions, mixing times longer than a
couple of minutes gave rise to significant amounts of ferric forms. All samples were frozen by
being immersed the the NMR tube in liquid nitrogen immediately after mixing. Some samples
contained ethylene glycol or glycerol, and the spectral results obtained were the same as for
protein with a solution of only buffer.

Sample Preparation for Fourier Transform Infrared Spectroscopy (FTIR)

Ferrous CO samples for FTIR measurement were made only for samples bound with 22R-OHCH
and 20R,22R-DiOHCH, the value for the CH-bound sample being available from the rR data. The
ferrous CO samples were made by adding a minimal amount of Na2S2O4 powder to the COsaturated ferric sample prepared with 100 mM phosphate buffer containing 0.1 mM EDTA and
0.1 mM DTT in a 2 mL glass vial sealed with a rubber septum and then incubating for 15 min at 4
°C to ensure full ligation. While addition of solid dithionite can cause changes in pH it is when
added in excess, care was taken to add very small amounts; it is noted that the FTIR spectra for
these and similarly prepared samples of CO adducts of other P450s yielded spectra identical to
those prepared by Tsubaki et al. and others.(30, 50-52) Then the ferrous CO sample was
transferred as quickly as possible to the FTIR cell, which had already been flushed with CO gas.
The concentrations of the protein for the FTIR samples were 200–300 μM.

Resonance Raman Measurements

Ferric CYP11A1 samples were measured using the 406.7 and 356.4 nm excitation lines, while the
Fe(II)–CO adducts were excited by the 441.6 nm line provided by a He–Cd laser (IK Series,
Kimmon Koha Co., Ltd.). Multiple excitation lines, including the 356.4, 406.7, and 415.4 nm lines
from a Kr+ laser (Coherent Innova Sabre Ion Laser) and 441.6 nm from the He–Cd laser, were
employed to try to enhance the ν(O–O) modes of the oxy samples, but ν(O–O) and ν(Fe–O)
features with adequate signal-to-noise ratios were obtained only when using the 415.4 nm

krypton lines or the 441.6 nm line from the He–Cd laser; it is noted that in many studies of
dioxygen complexes of cytochromes P450, adequate enhancement of the internal modes of the
Fe–O–O fragment is obtained with the 413 nm krypton line, but enhancement is slightly better
with the 415.4 nm excitation used here. The rR spectra of all samples were collected using a
Spex 1269 spectrometer equipped with Spec-10 LN-cooled detector (Princeton Instruments).
The slit width was set at 150 μm, and a 1200 g/mm grating was used; with this grating, the
resultant spectral dispersion is 0.46 cm–1/pixel.
The laser power for the ferric sample was adjusted to ∼10 mW, whereas for the ferrous CO
adducts and oxy samples, it was kept at ∼1 mW to minimize photodissociation. Moreover, to
avoid laser-induced heating and protein degradation, the samples were contained in spinning
NMR tubes. The 180° backscattering geometry was used for all measurements, and the laser
beam was focused onto the sample using a cylindrical lens, to form a line image to improve the
collection efficiency at a given photon flux at the sample surface.(66) The ferric and ferrous CO
samples were measured at room temperature, while the oxy samples were measured at 77 K,
employing an in-house designed immersion dewar, fitted with a NMR tube sample spinning
device. Spectra were calibrated with fenchone (Sigma-Aldrich) and processed with Grams/32 AI
software (Galactic Industries, Salem, NH).

FTIR Measurements

The infrared spectra were recorded using a 4020 Galaxy Series FTIR spectrometer from Matson
Instruments. The IR OTTLE33 cell purchased from New Era, when equipped with a Teflon spacer
with a 0.1 mm width placed between two CaF2 windows, requires only 60 μL of sample for each
measurement. The infrared spectrophotometer was run in single-beam mode. A spectrum was
recorded with no sample cell present (i.e., air) to serve as a blank, and then six separate spectral
traces of the ferric sample (each with 500 scans) were collected; the same procedure was used
for collection of the ferrous–CO samples. The presented data are the difference spectra
between the ferrous–CO and ferric samples; as mentioned above, the enzyme concentrations
for these samples were 200–300 μM.

Results and Discussion
While a large majority of cytochrome P450-mediated oxidations proceed through the
Compound I intermediate arising from proton-assisted O–O bond cleavage of the precursor
ferric peroxo species, any conditions that effectively restrict protonation of the latter can
facilitate its attack on susceptible bound substrates.(55-57, 67-70) Indeed, rR evidence of the
presence of a H-bonding interaction with the proximal oxygen of the (Fe–Op–O) fragment has
recently been obtained, which supports this mechanism in the case of the C–C bond cleavage
reaction that occurs for 17-hydroxy-pregnenolone (17-OH PREG) processing by CYP17A1;(43,
53) on the other hand, a H-bonding interaction with the terminal oxygen of the Fe–O–
Ot fragment disfavors such a reaction, facilitating the multistep protonation and O–O bond
cleavage process that leads to formation of the Compound I species.(16-22) Indeed, rR data
recently acquired for the dioxy complexes of CYP19 revealed spectral patterns consistent with
H-bonding to the distal oxygen atom of the Fe–O–O fragment, suggesting the likely involvement
of Compound I mediation of the C–C bond cleavage process that produces estrone

product,(44) a conclusion that is in essential agreement with recent kinetic studies reported by
Sligar and co-workers.(71)
Given that rR spectroscopy provides an especially effective probe of these functionally
important H-bonding interactions with the Fe–O–O fragments of dioxy intermediates, it has
herein been used to probe the dioxygen complexes obtained for CYP11A1 bound with each of its
three natural substrates, CH, 22R-OHCH, and 20R,22R-DiOHCH. However, before proceeding to
a discussion of the new results obtained for the dioxygen adducts, to help clarify certain
nebulous or incomplete results reported in previous studies,(50-52) we undertook additional rR
studies to further define active site structural differences that exist for the ferric and ferrous CObound forms with each of the three physiologically relevant substrates. In addition, these
studies provide further definition of the effects of adrenodoxin binding on the heme structure
and its interactions with active site structural elements, including the Fe–S bond between the
heme and the cysteine residue, a functionally crucial linkage that can be manipulated by slight
structural alterations within the proximal heme pocket where adrenodoxin binding occurs.(2327)

Ferric CYP11A1 and Its Interaction with Adrenodoxin

Early rR studies of this enzyme were reported by Tsubaki et al.(50-52) for the ferric and ferrous
CO states, providing valuable insight into its active site structure. However, the interpretations
of some of these data were hampered by the presence of strong glycerol bands that overlap
with some structure-sensitive heme vibrational modes. Compared with previous work, the data
presented below were acquired from samples prepared under aqueous conditions without
glycerol, ethylene glycol, or detergent, each of which was present in the previous study and
complicated the interpretation by the presence of the additives’ Raman bands in the lowfrequency and high-frequency regions; e.g., a high-intensity and wide glycerol band appearing at
∼1467 cm–1 complicates observation of the ν3 mode of the HS species, which occurs near 1484
cm–1,(50-52) an overlap that can directly lead to the wrong interpretation of the spin population.

Now turning our attention to the newly acquired data, we present the rR spectra of ferric
CYP11A1 samples with CH, 22R-OHCH, and 20R,22R-DiOHCH substrates in high- and lowfrequency regions, as well as in the presence of the natural redox partner, adrenodoxin (Adx),
in Figure 2. The high-frequency spectra were normalized to the ν4 mode at 1370 cm–1, and the
low-frequency region was normalized to the ν7 mode near 674 cm–1; neither of these strong
modes is included in these traces to allow a clearer presentation of the lower-intensity
structure-sensitive heme modes. The assignments of the modes were performed according to
the previous published data on cytochromes P450s and model compounds of Nioctaethylporphyrin.(29, 72)

Figure 2. Ferric forms for different substrates in buffer comprising 100 mM phosphate (pH 7.4),
0.1 mM DTT, and 0.1 mM EDTA. The excitation line was 406 nm, and the acquisition time was 60
min for the low frequency and 30 min for the high frequency at room temperature.

High-Frequency Region

The spectra of cholesterol (CH)-bound samples (Figure 2A, right panel) show components
associated with the high-spin (HS) and low-spin (LS) states. The population of the high-spin state
is larger than that of the LS state as seen by the higher intensity of high-spin markers ν3 at 1484
cm–1, ν2 at 1567 cm–1, and ν10 at ∼1621 cm–1 as compared to the corresponding low-spin makers,
which are seen at 1500, 1581, and 1637 cm–1, respectively. It is noted that the HS ν10mode
overlaps with the vinyl stretching modes that are seen more clearly in the spectrum of
LS.(33) Binding of 22R-OHCH induces an almost complete low-spin state conversion, as seen by
the presence of the dominant LS state markers ν3 at 1500 cm–1, ν2 at ∼1582 cm–1, and ν10 at
1637 cm–1. The absence of the HS ν10 mode in this region (now appearing for the LS state at
1637 cm–1) reveals the existence of two vinyl stretching modes at 1618 and 1627 cm–1, the
lower-frequency one usually being associated with the in-plane conformation of a vinyl group
and the higher-frequency one being associated with the out-of-plane conformation.(32, 38) The
fact that the 22R-OHCH substrate does not induce high-spin conversion is not surprising, given
the fact that the crystal structure of CYP11A1 with this substrate shows that there is a large
amount of electron density between the O atom of the hydroxyl group attached to the position

22 carbon of the substrate and the heme Fe, with the distance between the O and Fe being only
2.56 Å, indicative of a covalent bond between the heme iron and substrate.(28, 73) This
observation is entirely consistent with the rR data presented here and generally consistent with
those previously published.(50-52) On the other hand, binding of 20R,22R-DiOHCH induces a
mixture of spin states (76% HS) similar to, but slightly larger, than that seen for the CH-bound
sample (63% HS) (Figure 2E); i.e., interestingly, this diol-containing substrate does not
coordinate to the heme. The stated spin state populations for all three enzyme–substrate
complexes were calculated using previously published HS/LS cross section ratios for
cytochromes P450.(31)

Low-Frequency Region

The low-frequency spectrum of the CH-bound sample (Figure 2A, left panel) shows the presence
of the propionate bending mode at 379 cm–1 and the vinyl bending mode at 420 cm–1. For the
22R-OHCH-bound sample, an additional propionate bending mode at 363 cm–1 is activated, a
frequency that generally signals the presence of a propionate group experiencing a weaker Hbonding interaction with active site fragments.(32, 41) Moreover, a small band appearing at 396
cm–1 was also enhanced and can be reasonably associated with weak activation of an in-plane
vinyl bending mode. The presence of two vinyl bending modes associated with in-plane (396 cm–
1
) and out-of-plane (420 cm–1) vinyl group conformations in the low-frequency region of the rR
spectrum of the 22R-OHCH-bound sample is indeed quite consistent with the two vinyl
stretching frequencies observed in the high-frequency region, as discussed above (Figure 2C).
Again, the binding of the third substrate (Figure 2E, left panel) shows a spectral pattern quite
similar to that of the CH-bound samples.

Effect of Adrenodoxin on the Ferric State

As can be seen from the slightly increased intensity of ν3 spin state markers at ∼1484 cm–1 from
panels B, D, and F of Figure 2, for all three substrates, the addition of Adx to the samples of
CYP11A1 causes only very small increases (5–10%) in the high-spin population, as determined
from the previously referenced procedure,(31) with the detailed data being found in Table S1. It
was reported previously, using ultraviolet–visible and resonance Raman spectroscopies, that the
redox partner, Adx, promotes formation of more high-spin component; e.g., for the CH-bound
form, it was reported that upon binding of Adx the HS population increased from only ∼50% to
complete transformation to HS.(50) While the results presented here did not show such large
spin state changes, it has to be noted that the previous rR results were collected on samples
that contained glycerol or propylene glycol, whose vibrational modes overlapped the HS state
marker band at ∼1484 cm–1, making it difficult to properly determine the percentage of the HS
component.(50, 51) It is emphasized that with the experimental conditions being used here, the
ν3 marker band is quite isolated. In addition, studies we performed using the same experimental
condition as previously described with proteins prepared in buffer containing 20% glycerol still
gave no significant changes in the spin state when Adx was added (data not shown). The effect
of adrenodoxin binding on the rR spectra in the low-frequency region is also insignificant, as
seen by the lack of changes in the pairs of traces A and B, C and D, and E and F (Figure 2, left
panel).

Iron–Sulfur Linkage

Obviously, the nature of the linkage between the heme prosthetic group and a given associated
protein is quite important for dictating the reactivity patterns of the enzyme.(74-77) Indeed, the
Fe–S linkage of cytochromes P450 and some related enzymes plays a key role in enabling these
enzymes to mediate such remarkable chemical transformations under normal physiological
conditions.(1-3) Fortunately, it has been well established that rR spectroscopy, when employing
a near-ultraviolet excitation wavelength (e.g., near 350–360 nm), is one of the most effective
probes of the status of this key Fe–S fragment, providing an easily identifiable ν(Fe–S) band in
the low-frequency rR spectrum.(45-47) Specifically, the behavior of this mode can be
documented to evaluate the linkage between the heme Fe and the endogenous cysteine
thiolate ligand, the strength of which can be modulated by structural alterations within the
proximal heme pocket, the most effective perturbations arising by interaction with natural
redox partners such as Adx, which typically bind to the proximal side of the active site.
Several studies have consistently shown that the precise structures of substrates, all of which
bind within the distal pocket of cytochromes P450, have little or no effect on the Fe–S
linkage.(46-48, 78) However, we anticipate that interactions with redox partners can impact the
status of the Fe–S linkage.(46, 48, 79) Results of our work are shown in Figure 3, where ν(Fe–S)
is observed at 347 cm–1 for CYP11A1 bound with CH, with no detectable change being seen upon
binding of Adx. This is an unexpected result inasmuch as significant effects on the ν(Fe–S) mode
are commonly seen for these types of interactions; e.g., binding of putidaredoxin to P450cam
caused a strengthening of the Fe–S bond, as witnessed by a shift in ν(Fe–S) by ∼3 cm–1 to a
higher frequency.(46) In addition, a differential effect on the Fe–S bond was seen for
interactions of CYP2B4 with cytochrome b5 versus CPR.(48) More recently, studies of nanodiscassociated CYP17 also provided evidence that binding of cytochrome b5 induces a 3 cm–1 shift of
the ν(Fe–S) mode to a higher frequency.(79)

Figure 3. Low-frequency rR spectra of ferric cholesterol-bound CYP11A1 in 10 mM phosphate
buffer (pH 7.4), 0.1 mM DTT, and 0.1 mM EDTA. The excitation line was 356.4 nm, and the
acquisition time was 60 min at room temperature.

Ferrous–CO Adduct and Its Interaction with Different Substrates and
Adrenodoxin

Resonance Raman spectroscopic interrogation of the ferrous CO adducts of heme proteins has
long been established as an effective probe of proximal-pocket and especially distal-pocket
active site structure. The internal modes of the Fe–C–O fragment report on the strength of the
Fe–L linkage with the trans-axial proximal ligand and simultaneously reflect steric and polar
interactions with distal-pocket residues, including those presented by the enzyme-bound
substrate,(42, 80-82) the latter interaction being crucially important for cytochromes P450, such
as the CYP11A1 being studied here. Basically, increases in the degree of dπ(Fe) to CO(π*) backbonding in the Fe–C–O fragment, leading to increases in the positive polarity of the distal-pocket
environment, strengthen the Fe–C bond while simultaneously weakening the C–O bond,
resulting in a negative correlation between the ν(Fe–C) and ν(C–O) vibrational modes.(42, 8082)
While rR spectroscopy has been applied previously to interrogate the active site of the CO
adducts of CYP11A1 with various substrates,(50-52) one troubling issue occurred with the
ferrous CO adducts, where it was reported that the rR spectrum of the 22R-OHCH-bound sample
contained only one ν(Fe–C) stretching frequency, while the IR data clearly revealed the presence
of two ν(C–O) stretching modes. The most reasonable explanation of this unexpected behavior
is unintentional photodissociation of CO of one of the conformers during the Raman
experiment. In our work, attempts are made to clarify the interpretation of the vibrational

spectra of the ferric and ferrous CO adducts for all three physiologically important substrates
and to further evaluate the effect of Adx binding on the Fe–C–O fragment of the CO adducts of
CYP11A1.
The rR spectra acquired for the low-frequency region are shown in Figure 4.

Figure 4. Low-frequency rR spectra for CO adducts of CYP11A1 with different substrates in 100
mM phosphate buffer (pH 7.4), 0.1 mM DTT, and 0.1 mM EDTA. The excitation line was 441.6
nm, and the acquisition time was 60 min at room temperature.
The most obvious finding that is noted upon initial inspection of the data is that there are no
observable effects of Adx binding upon the status of the Fe–C–O fragment. In similar studies
reported previously by others,(52) the changes in Adx binding were reported to be quite small
(between 0 and 1.5 cm–1). However, the apparent existence of these small effects, along with
the presence of some confusing results of those spectral studies, prompted us to reexamine this
issue. For example, in those earlier studies, it was reported that in some cases, including the
sample containing the 22R-OHCH, while two ν(C–O) modes could be observed by FTIR, only a
single ν(Fe–C) mode could be observed by rR. As shown below, these confusing results can be
readily explained by the occurrence of unintended photodissociation for the ferrous CO adducts
by the rR laser excitation beam.

Now, returning to consider the effects of different substrates on the Fe–C–O fragment, we find
the sample bound with cholesterol, a substrate that presents no hydrophilic R–OH fragments to
the bound CO ligand, shows a clear and relatively sharp ν(Fe–C) mode appearing at 482 cm–1, a
value in good agreement with the previous work,(51) and the corresponding ν(C–O) being
observed in the FTIR spectrum at 1952 cm–1, again a value in reasonably good agreement with
that reported previously (i.e., 1954 cm–1).(51) In contrast to the relatively simple spectral
signature displayed for the CO adduct of the CH-bound enzyme, the CO adduct formed for the
enzyme bound with the more polar substrate, 22R-OHCH, whose C22–OH fragment is
apparently close enough to the iron binding site to have induced a LS spin state by direct
interaction with the heme iron as evidenced in the rR data for the ferric state (Figure 2), gave
three observed features appearing in the region where the ν(Fe–C) modes are expected to
appear, i.e., at 482, 500, and 515 cm–1. To clarify the interpretation of the spectra acquired for
the 22R-OHCH substrate, the Fe(II)–12C16O and Fe(II)–13C16O samples were made and measured
with the results being shown in Figure 5. It is clear that both 481 and 515 cm–1 bands seen in
trace A shifted down by 5 cm–1 in the spectra of the 13C16O isotope, confirming their assignments
to ν(Fe–C) modes. On the other hand, the feature observed at 500 cm–1 does not shift upon
substitution with 12C and/or 13C, securing its assignment to a heme mode. The assignment of the
481 and 515 cm–1 bands to two different Fe–C–O conformers is supported by observation two
high-frequency ν(C–O) modes at 1952 and 1934 cm–1 in the FTIR spectrum, as shown in Figure 6.
In previously published work,(51) the appearance of only one band at a low frequency was
reported for this complex, an observation that may be due to accidental photodissociation
perhaps caused by either a high laser power (∼5 mW) or ineffective spinning during the
measurement. Indeed, results of experiments to verify photosensitivity for this complex are
shown in the bottom two traces of Figure 5, where it is seen that in the spectra acquired at high
photon flux (traces C and D), there is a strong and wide heme mode, with its expected
insensitivity to the 13C16O substitution that overlapped with the ν(Fe–C) modes. From previously
published data, it was reported that only one ν(Fe–C) mode could be detected (at 479 cm–1) for
the 22R-OHCH-bound CYP11A1 complex. Obviously, this could have arisen from the heme mode
seen at 479 cm–1 in the photodissociated sample we have generated in the work presented here
(Figure 5, traces C and D).

Figure 5. Isotope effect of 22R-OHCH CO adducts in buffer comprising 100 mM phosphate (pH
7.4), 0.1 mM DTT, and 0.1 mM EDTA. The excitation line was 442.4 nm, and the acquisition time
was 60 min at room temperature. Ferrous CO adducts with (A) a 12CO isotope and (B) a 13CO
isotope and their photodissociated forms (C and D, respectively).

Figure 6. FTIR results for high-frequency CYP11A1 with substrate 22R-OHCH and 20R,22RDiOHCH ferrous CO forms in 100 mM phosphate buffer (pH 7.4), 0.1 mM DTT, and 0.1 mM
EDTA.
Given these clarified spectral traces for the 22R-OHCH-bound ferrous CO adduct, the most
reasonable conclusion for this species is that this directed C–O–H group interacts with the Fe–C–
O fragment to produce two different Fe–C–O conformers. Furthermore, it is also quite
reasonable to conclude that the appearance of two ν(Fe–C) and two ν(C–O) modes for the
20R,22R-DiOHCH-bound substrate can also be attributed to interactions of one or both C–OH
groups with the Fe–C–O fragment; indeed, the two pairs of ν(Fe–C)/ν(C–O) frequencies are quite
similar for both complexes. From this collective data set for the three substrates, it seems likely
that (for the second and third substrates) the presence of one C–OH group positioned quite near
the Fe–C–O fragment leads to two Fe–C–O conformers, one with a disposition similar to that of
the “unperturbed” Fe–C–O conformer of the CH-bound enzyme and the other reflecting a
reasonably strong H-bonding interaction with the C–OH group present on the substrate.

Effects of Substrate Structure and Adx Binding on the Fe–O–O Fragment of
Dioxygen-Ligated Intermediates of CYP11A1

As discussed above, recent rR studies of the oxy intermediates of CYP17 and CYP19,(43,
44) along with analogous studies of NOS,(59, 67, 69, 70, 83) have shown that this technique is
effective in detecting subtle structural differences in H-bond interactions with the Fe–O–O
fragment. Specifically, donation of a H-bond to the proximal oxygen (Op) of the Fe–Op–
Ot fragment, detected for the dioxy adduct of the 17-OH PREG sample,(43) which has recently
been shown by rR spectroscopy to persist upon reduction to the peroxo
intermediate,(53)stabilizing it for attack on susceptible substrates, exhibits a relatively low ν(Fe–
O) frequency (528 cm–1). On the other hand, H-bonding to the terminal oxygen (Ot) of the Fe–
Op–Ot fragment of the 17-OH PROG-bound sample, which exhibits a relatively high ν(Fe–O)
frequency of 546 cm–1,(43) promotes formation of the hydroperoxo intermediate, ultimately
leading to O–O bond cleavage and Compound I formation, an intermediate that effectively
mediates the more extensively studied hydroxylation reactions. Clearly, the rR technique is an
important tool for documenting these structural variations that, nevertheless, carry profound
functional consequences.(14, 15)
Given this demonstrated utility of rR spectroscopy for structural definition of these active site
Fe–O–O fragments, efforts were made here, for the first time, to acquire rR spectra of these
dioxygen adducts of CYP11A1 with all three natural substrates, seeking to detect any telltale
differences in the rR spectra that might reveal important H-bonding differences for the three
substrates, as well as allowing detection of rearrangements of such bonding interactions upon
association of CYP11A1 with Adx. To study these relatively unstable oxy intermediates
encountered within the catalytic cycles for these three natural substrates of CYP11A1, special
procedures were required, as summarized earlier in Materials and Methods. Inasmuch as no
differential effects of the three substrates on the Fe–S linkage in the heme proximal pocket
were seen in the studies of the ν(Fe–S) modes (vide supra), all effects observed here are
presumed to arise from distal side structural perturbations.

Cholesterol-Bound OxyCYP11A1

The 415.4 nm line from a krypton ion laser, which is in resonance with the Soret transition of the
CH-bound CYP11A1, was used to measure this complex. It is noted that, because of the
relatively low signal-to-noise ratio that can be attained for these frozen oxy–CYP samples,
definitive identification of the key internal modes of the Fe–O–O fragments is most readily
accomplished via generation of the 16O2/18O2 difference traces, which are shown in Figure 7. The
ν(O–O) modes are seen in the high-frequency region, shown as traces A and B (large spectrum)
for samples with and without Adx, respectively. The ν(Fe–O) modes, seen in the low-frequency
region, are shown as traces A and B (small spectrum) for oxyCYP11A1 with and without Adx.

Figure 7. Oxy samples for all the substrates with and without Adx in 100 mM phosphate buffer
containing 0.1 mM EDTA and 0.1 mM DTT. The insets above show the ν(Fe–16O) – ν(Fe–18O)
difference features.
In the low-frequency spectra, the ν(Fe–16O) mode is assigned at 546 cm–1 and the ν(Fe–18O) at
518 cm–1 for the cholesterol-bound form, a shift of 28 cm–1(calculated shift of 25 cm–1). As was
outlined above in the first paragraphs of this section, this set of values for ν(Fe–O) and ν(O–O) is
quite similar to that obtained for camphor-bound oxyCYP101 and for oxyCYP17 and oxyCYP19
with those substrates that are known to be converted via Compound I processing. The
conclusion emerging from this is that conversion of CH to 22-OHCH is also likely to proceed
through a Compound I intermediate. This finding has long been generally accepted, with recent
electron paramagnetic resonance (EPR) studies providing results that strongly support the
proposed involvement of Compound I in this first step.(60) Significantly, the sample prepared
with Adx exhibits a ν(Fe–16O) mode at 543 cm–1 and a corresponding ν(Fe–18O) mode at 515 cm–
1
; this ∼3 cm–1 downshift of ν(Fe–O) upon addition of Adx reflects a slight weakening of the Fe–
O bond when Adx is present. On the other hand, the ν(16O–16O) (at 1136 cm–1) and ν(18O–18O) (at
1072 cm–1) modes shift up to 1139 and 1075 cm–1, respectively, upon addition of Adx, the
combined results suggesting that the interaction with Adx might slightly weaken the H-bonding
interaction with the distal oxygen atom of the O–O bond.

22R-OHCH-Bound OxyCYP11A1

Figure 7 shows the difference spectra for this species, both in the absence and presence of Adx.
The high-frequency region (right panel, traces C and D) shows the same pattern that was
observed for the cholesterol-bound sample, exhibiting the ν(16O–16O) mode at 1135 cm–1, with
the ν(18O–18O) mode being observed at 1068 cm–1. Also, like that of the CH-bound sample, upon
Adx binding, the ν(16O–16O) mode shifts up to 1137 cm–1, with the corresponding ν(18O–18O)
mode appearing at 1070 cm–1, an isotopic shift in reasonable agreement with that expected for
a diatomic O–O oscillator (∼65 cm–1). Unfortunately, though numerous attempts to observe the
telltale ν(Fe–O) mode were made, employing multiple excitation lines, including the 441.6 nm
line from a He:Cd laser, no evidence was obtained for its enhancement. These efforts are
summarized in the Supporting Information, along with a discussion of structural and electronic
factors that can affect the degree of resonance enhancement of the modes that are essentially
isolated to the Fe–O–O fragment. In the absence of observable ν(Fe–O) modes, it is not possible
to draw conclusions about the status of the Fe–O–O fragment with respect to its disposition
toward the O–O bond cleavage process involved in the hydroxylation pathways. Nevertheless,
the well-documented generation of the 20R,22R-DiOHCH product is consistent with the
proposal that a Compound I intermediate is involved. Indeed, recent experimental work
reported by Hoffman and co-workers, employing cryoradiolysis studies with EPR detection, has
provided convincing arguments for this assertion.(60, 61)

20R,22R-DiOHCH-Bound OxyCYP11A1

Figure 7 also shows the difference spectra obtained for the oxy complexes of the 20R,22RDiOHCH-bound CYP11A1 complex with and without Adx. The difference patterns for the spectral
region containing the ν(O–O) modes were measured with Soret excitation (415.4 nm), as was
done for the previous substrates. However, no clear difference pattern for ν(Fe–O) could be
observed in the low-frequency region. The same efforts were employed that were used to try to
enhance the ν(Fe–O) modes of the 22R-OHCH sample (vide supra). In this case, the ν(Fe–O)
mode was effectively enhanced using the 441.6 nm excitation line from the He:Cd laser. The
data acquired for the enzyme bound with the third substrate, 20R,22R-DiOHCH, reveal the ν(Fe–
16
O) stretching mode at 542 cm–1 and the ν(16O–16O) mode at 1135 cm–1. Interestingly, the effect
of Adx binding on this species is the opposite of its effect on the enzyme bound with the first
two substrates; i.e., binding of Adx to the samples containing the first two substrates increases
the strength of the O–O bond, simultaneously decreasing the strength of the Fe–O bond [in the
case of the CH-bound form, wherein Raman scattering by the ν(Fe–O) mode is enhanced], while
Adx binding on the sample containing 20R,22R-DiOHCH increases the strength of the Fe–O bond
and decreases the strength of the O–O bond.
A key finding in the studies of these oxy complexes with the three natural substrates is that the
CYP11A1–CH oxy complex yields frequencies for the ν(Fe–O) and ν(O–O) modes that are very
similar to those obtained for the oxy complex of CYP11A1 bound to 20R,22R-DiOHCH; i.e., both
are quite similar to those seen for the oxy complex of P450cam complexes and those observed
for oxyCYP17A1 bearing the 17-OH PROG substrate, all of which encounter hydrogen bonding
interactions involving the terminal oxygen of the Fe–O–O fragment, interactions that promote
O–O bond cleavage and Compound I formation.(18, 44, 71) This leads to the conclusion that the
bond cleavage step likely proceeds through the Compound I intermediate, in agreement with

previous work.(60, 61) With the addition of Adx, the ν(Fe–O) frequency increases, indicating the
strengthening the Fe–O bond; the observed decrease in the ν(O–O) frequency indicates the
corresponding weakening the O–O bond. Both of these shifts are consistent with donation of a
slightly stronger hydrogen bond to the terminal oxygen, a change that would lower peroxoreactivity and further promote O–O bond cleavage of the Fe–O–O fragment and formation of
Compound I.

Relationship of Findings from rR Spectroscopy to Recent EPR and Electron
Nuclear Double Resonance (ENDOR) Work

Finally, it is of interest to point out that results reported for EPR and ENDOR studies of CYP11A1,
with all three physiologically important substrates,(60, 61)provide indirect evidence from
analysis of cryoreduced samples that the enzyme substrate complexes formed with each of
these three substrates gave rise to oxy complexes existing in three different conformations, with
H-bonded forms generating hydroperoxo species following cryoradiolysis at 77 K, while non-Hbonded oxy precursors yielded either a ferric–peroxo species or, in the special case of 22OH–CH,
a ferrous–superoxo species.(60, 61, 84) In support of this argument, detailed analysis of the rR
spectra of these oxygenated precursors shown in Figure S1 is consistent with the presence of
three conformers in each of the substrate-bound forms, as had been deduced from analysis of
the observed EPR and ENDOR spectra of the cryoreduced samples.(60, 61) The only somewhat
surprising result from the earlier EPR work is that, while a non-H-bonded form in the oxy
complex when CH is bound gives rise to a peroxo species at 77 K, the non-H-bonded species in
the oxy complex with the 22-OH–CH substrate was correlated with a ferrous–superoxo species
in the cryoreduced sample;(60, 61) i.e., the two samples display similar rR spectra of the oxy
precursors but give rise to two different formulations of isoelectronic species in the cryoreduced
forms. One possible explanation arises upon consideration of subtle but potentially effective Hbonding differences that might exist in these two cases. Thus, while the C22–OH fragment of
bound 22-OH–CH is known to coordinate to the heme iron, neither the C20–OH groups nor the
C22–OH groups coordinate to the heme iron when 20,22-DiOH–CH is bound; i.e., there are
apparently critical active site H-bonding interactions that position the 22-OH fragment of only
the 22-OH–CH substrate in an orientation that directs the unpaired electrons to interact with
the heme iron. Such interaction might persist in both the dioxy and cryoreduced sample, such
that the lone pair interacts directly with the bound Fe–O–O superoxo fragment, favoring the
generation of the ferrous–superoxo rather than the ferric–peroxo formulation.

Summary

These newly acquired rR data for the ferric and ferrous CO forms of CYP11A1 are partially
consistent with what was published previously but also clarify certain ambiguities arising from
the apparent photodissociation of CO during the measurement in the case of the complex
between 22R-OHCH and CYP11A1 in the ferrous–CO form.(50-52) The data presented in this
work clearly show that the enzyme bound with the non-H-bonding substrate, CH, yields only one
set of vibrational modes for the CO adduct, i.e., ν(Fe–C) at 482 cm–1 and ν(C–O) at 1952 cm–1. On
the other hand, for the two substrates possessing hydroxyl substituents that are well positioned
to H-bond with the bound Fe–C–O fragment, two sets of Fe–C–O vibrational modes are seen.
Thus, for both enzyme–substrate complexes, ν(Fe–C) and ν(C–O) are seen at 482 and 1954 cm–1,

respectively, which are quite similar to those observed for the non-H-bonding CH substrate. On
the other hand, the presence of one or two H-bonding hydroxyl groups near the Fe–C–O
fragment generates a new set of modes having the ν(Fe–C) mode at 515 cm–1 (or 510 cm–1) and
the ν(C–O) mode at 1934 cm–1, both sets of data being entirely consistent with H-bonding to the
Fe–C–O fragment. The data acquired for the protein–protein complex between CYP11A1 and
Adx also show the effect of Adx on the active sites of the ferric– and ferrous–CO forms to be
minimal.
Finally, this first study of the rR spectra of the dioxygen adducts of CYP11A1 with all three
substrates revealed vibrational spectral patterns that are quite similar. On the basis of
conclusions drawn from work on dioxygen adducts of several other cytochromes P450, including
CYP101, CYP17, and CYP19, the ν(Fe–O) and ν(O–O) frequencies observed here are those
expected for the Fe–O–O fragment that is eventually converted to the Compound I
intermediates upon reduction. Though it can be argued that the effective H-donor for the
various cases might be different [i.e., water for CH and substrate hydroxyl group(s) for the other
two substrates], the Fe–O–O fragment in each case is apparently poised to generate the classic
Compound I active oxidant. Finally, it is noted that, unlike the CO adducts, binding of
adrenodoxin does have a significant impact on the status of the dioxygen complexes,
presumably because of an Adx-induced change in H-bonding to the Fe–O–O fragment, which is
known to be more sensitive to this interaction than are Fe–C–O fragments.(42)
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Isolation and purification of CYP11A1 and Adrenodoxin
In the first step, the external fat and connective tissue were removed from the tough, shiny exterior membrane
(capsule) of the adrenal glands. Each adrenal gland typically weighted ~15-30 grams and was then processed as
follows. The gland was carefully sliced, using a surgical scalpel, into two parts along the long axis, exposing the
interior. The interior comprises yellowish central region, called the medulla, surrounded by a reddish brown
major region called adrenal cortex. The adrenal cortex contains the targeted CYP11A1, as well as several other
CYP isoforms, including CYP11B, as well as redox partners, the adrenodoxin (Adx) and adrenodoxin reductase
(AdR).1 The medulla was removed using a scalpel and tweezers and discarded. The adrenal cortex matrix was
carefully scraped off from the capsule and temporarily stored on an ice-cooled glass plate; this removal is most
effectively performed by holding the capsule with a tweezers while scraping away the cortex. Having collected
the cortex matrix from ~20 glands, the material is repeatedly sliced and chopped into a rough, slightly lumpy
paste and suspended in 4 volumes of 0.25 M sucrose solution containing 10 mM phosphate pH 7.4, 0.1 mM
ethylenediaminetetraacetic acid (EDTA) and 0.1 mM dithiothreitol (DTT). This suspension was homogenized
using a Potter Elvejhem (piston/tube) type homogenizer to yield a thick, smooth suspension, which was then
centrifuged at 4 °C 500xg for 10 minutes to remove the unbroken cells and nuclei. The supernatant was then
centrifuged again at 11,000xg for 30 minutes at 4 °C to yield a reddish solution and a brown pellet of
mitochondria.

The mitochondrial pellets were re-suspended in 20 mM phosphate buffer, 0.1 mM EDTA, 0.1 mM
DTT. The mitochondrial suspension (50 mL portions) was placed into an ice bath and sonicated with a Branson
Sonifier 450 probe type sonicator at a power setting of 3.0, forming a voluminous froth, but making sure
to maintain the temperature of the suspension below 4 °C. The solution was centrifuged for 1 hour at
100,000xg and the resulting sub-mitochondrial pellets were re-suspended in 100 mM phosphate buffer, 0.1
mM EDTA, 0.1 mM DTT to yield a protein concentration of 15 mg/ml. Sodium cholate (10%) was added to the
solution of sub-mitochondrial suspension to yield a 1% cholate concentration and the sub-mitochondrial
particles were extracted for 1 hour. The suspension was centrifuged for 1 hour at 100,000xg and the
supernatant recovered. An ammonia sulfate fraction procedure was used to further purify the extracted
proteins.2 In the first step, ammonium sulfate was added to bring its concentration to 30%, with the resulting
precipitate (containing CYP11B1)1 being discarded or stored, as desired. Then additional ammonium sulfate
was added to the supernatant to bring its concentration to 45%, at which point a precipitate containing the
targeted CYP11A1 formed, which was then collected by centrifugation. The pellets were suspended in 100 mM
phosphate buffer containing 0.1 mM EDTA and 0.1 mM DTT. The CYP11A1 was isolated by chromatography
using octyl sepharose column that was first washed with original buffer containing 0.03% cholate, followed by
protein elution using the original buffer containing 0.3% cholate. The fractions with Rz of A390/A280 larger than
0.6 were collected. The final Rz value was ~0.65 after pooling all the fractions together. The yield of CYP11A1 is
about 25 mg protein/ 500g glands.
The concentration of CYP11A1 was determined using UV-Vis absorption spectroscopy of ferrous-CO
adducts and the reduced form as reference. The difference between the absorbance measured at 450 nm and
490 nm was used to calculate the concentration, based on the reported differential extinction coefficient of 91
cm-1 mM-1. 3 The concentration of Adx was calculated based on the extinction coefficient 11 cm-1 mM- 1 at 414
nm.3

Enhancement of ν(Fe-O) and ν(O-O) by different excitation lines
The lack of the ν(Fe-O) mode enhancement in the CYP11A1 samples with 22R- OHCH substrate was
unexpected, prompting further investigations. The oxy adducts of cytochromes P450 exhibit an electronic
structure similar to that of ferric state; e.g., they possess a strong Soret band that arises from the π to π*
transition between Fe and porphyrin. In early studies, Soret excitation was used to study ferric P450 4 and then
this excitation was extended to studies of oxy samples of P450s. 5–7 The Density functional theory (DFT)-based

calculation on an iron porphine in its oxy complex was reported, 8 showing that there are 16 electronic
excitations corresponding to 38 electronic transitions from 280 nm to 471 nm for the fragment of S-Fe-O-O. It
has been shown previously, that the oxy P450cam and its D251N mutant can be efficiently studied using 356 nm
and 413 nm excitation lines. 5,9 Furthermore, it has been reported that the ν(O-O) mode of oxy P450cam can be
detected using 420 nm and 442 nm excitation lines.6,10 The intensity of ν(O-O) mode of P450cam increases as
excitation line increases from 356 nm, 413 nm and 420 nm, and 441 nm while the intensity of ν(Fe-O) mode
decreases from 356 nm to 413 nm, with no ν(Fe-O) being detected by using 420 nm.5,6,9,10 The CYP11A1 samples
containing 22R-OHCH substrate were measured employing the 356.4 nm, 413.1 nm, 415.4 nm and 441.6 nm
excitation lines. Interestingly, while the ν(O-O) mode was relatively well enhanced with first three excitation
lines, it was not observed with 441,6 nm excitation. Even though the ν(O-O) mode was strongly enhance for
some excitation, the ν(Fe-O) mode was not enhanced using any of these excitation lines. It is noted that the
presence of glycerol contributes greatly to increased fluorescence background of these frozen samples. Such
high background might obscure weak ν(Fe-O) bands. In order to lower the fluorescence background, the
CYP11A1 samples were prepared without the glycerol present. It has been noted that although the background
was indeed significantly reduced, the ν(Fe-O) mode was still not observed in the samples containing the second
substrate.
The possibility of accidental photodissociation was eliminated by making rR measurements of the
CYP11A1 samples in the spectral region that includes the ν(Fe-O) and ν(O-O) modes simultaneously; e.g., 4001200 cm-1. While the ν(O-O) mode was served, the ν(Fe-O) mode was absent.

Table S1 The calculated high spin population (%) in CYP11A1 in the presence of different substrates, without and
with Adx, in 100 mM phosphate buffer containing 0.1 mM EDTA and 0.1 mM DTT.
CYP11A1 bound to: Adx resonance Raman (% HS)

22R-OHCH
20R,22R-DiOHCH

+
+
+

63
73
8
13
76
82

Figure S1. The deconvoluted 16O2-18O2 difference traces in H2O buffer of oxy adducts of
CYP11A1 containing CH (A), 22R-OH (B) and 20R,22R-DiOHCH (C). The traces were
fitted using 50/50 % Gaussian/Lorentzian functions with band width of 10.0 cm-1 (±0.5
cm-1). It is noted that the deconvoluted data follow the same spectral pattern observed in
the experimental traces; e.g., Figure 7 of the manuscript.
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